Low doses of Interleukin-2 can cure large bovine Ocular Squamous Cell Carcinoma

W. Den Otter*, F. W.G. Hill, W. R. Klein, J. W. Koten, P. A. Steerenberg, P. H.M. De Mulder, V. P.M.G. Rutten, E. J. Ruitenberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Four cows bearing large Ocular Squamous Cell Carcinomas (BOSCC) were treated by 10 intratumoral injections (Monday-Friday for 2 consecutive weeks) of 200,000 U Interleukin-2 (Cetus). Tumors regressed in 2 out of 4 cases. This result shows that even large tumors may regress after local IL-2 treatment.

Original languageEnglish
Pages (from-to)2453-2455
Number of pages3
JournalAnticancer Research
Volume13
Issue number6 B
Publication statusPublished - 1993

Keywords

  • BOSCC
  • Bovine ocular squamous cell carcinoma
  • Cancer
  • Immunotherapy
  • Interleukin-2

Fingerprint

Dive into the research topics of 'Low doses of Interleukin-2 can cure large bovine Ocular Squamous Cell Carcinoma'. Together they form a unique fingerprint.

Cite this